Description:
Recombinant Monoclonal Antibody Production combines genetic engineering with scalable bioprocessing to create specific antibody therapies.
This approach enables consistent quality and rapid development for diagnostics and treatment, supported by optimized cell lines, purification strategies, and regulatory-compliant manufacturing workflows.
Social Media